paroxetine has been researched along with Body Weight in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.56) | 18.7374 |
1990's | 10 (25.64) | 18.2507 |
2000's | 19 (48.72) | 29.6817 |
2010's | 7 (17.95) | 24.3611 |
2020's | 2 (5.13) | 2.80 |
Authors | Studies |
---|---|
Acosta, A; Bielinski, SJ; Camilleri, M; Cifuentes, L; Decker, PA; Gonzalez-Izundegui, D; Hurtado, MD; Moyer, AM; Ricardo-Silgado, ML; Singh, S | 1 |
Ogunro, OB; Yakubu, MT | 1 |
Liebl, C; Müller, MB; Scharf, SH; Schmidt, MV; Sterlemann, V | 1 |
Bhaskar, S; Kaunitz, AM; Kazempour, K; Lippman, J; Mekonnen, H; Portman, DJ | 1 |
Pines, A | 1 |
Bachmann, G | 1 |
Breuer, ME; Campbell, U; Chan, JS; Groenink, L; Hanania, T; Korte, SM; Olivier, B; Oosting, RS; Schreiber, R; Snoeren, EM; Waldinger, M | 1 |
Terao, T | 1 |
Gutierrez, AM; Mohammadi, M; Weber, M | 1 |
Dadić-Hero, E; Kabalin, M; Medved, P; Pernar, M; Ruzić, K | 1 |
Lau, BW; Lee, TM; Leung, N; Li, SY; So, KF; Tang, SW; Wang, H; Wang, NL; Yau, SY | 1 |
Graham, DL; Morford, LR; Skelton, MR; Vorhees, CV; Williams, MT | 1 |
Bermudez, I; Franklin, M; Gaburro, S; Murck, H; Singewald, N | 1 |
Barbagli, B; Boissard, R; Fort, P; Gervasoni, D; Henninot, V; Luppi, PH; Panconi, E | 1 |
Bush, VL; Fone, KC; Marsden, CA; Middlemiss, DN | 1 |
Sari, Y; Xu, Y; Zhou, FC | 1 |
Aubel, B; Bourgoin, S; Farré, A; Hamon, M; Kayser, V; Mauborgne, A | 1 |
Bitter, I; Demitrack, MA; Detke, MJ; Mallinckrodt, CH; McNamara, RK; Wiltse, CG | 1 |
Nalepa, I; Roman, A | 1 |
Cools, AR; de Jong, TR; Olivier, B; Pattij, T; Snaphaan, LJ; Veening, JG; Waldinger, MD | 1 |
Bies, RR; Feng, Y; Ferrell, RE; Kimak, MA; Pollock, BG; Reynolds, CF | 1 |
Andreatini, R; Casarotto, PC | 1 |
Nagata, T; Nakayama, K; Ono, K | 1 |
Rowland, NE | 1 |
Barnes, GA; McCook, EC; Seidler, FJ; Slotkin, TA | 1 |
Hayashi-Kuwabara, Y; Ikeda, Y; Izumi, J; Kiuchi, Y; Oguchi, K; Tanaka, Y; Washizuka, M; Yoshinaga, K | 1 |
Huether, G; Rüther, E; Schmidt, S; Wiltfang, J; Zhou, D | 1 |
Cozzi, NV; Frescas, S; Huang, X; Marona-Lewicka, D; Nichols, DE | 1 |
Bissette, G; Fumagalli, F; McCook, EC; Miller, DB; Seidler, FJ; Slotkin, TA; Zhang, J | 1 |
Begg, EJ; Sainsbury, R; Wilkinson, TJ; Winter, AC | 1 |
Bielajew, C; Konkle, AT | 1 |
Christensen, HD; Coleman, FH; Gonzalez, CL; Rayburn, WF | 1 |
Connor, TJ; Kelly, JP; Leonard, BE; Nolan, Y; Shen, Y | 1 |
Blanchard, DC; Blanchard, RJ; Magariños, AM; McEwen, BS; McKittrick, CR; Sakai, RR | 1 |
Haack, M; Hinze-Selch, D; Kraus, T; Kühn, M; Pollmächer, T; Schuld, A; Uhr, M | 1 |
Begley, A; Mazumdar, S; Mulsant, B; Pollock, BG; Stack, J; Weber, E | 1 |
Chambers, PL; Kelly, JP; Leonard, BE; Ryan, PM | 1 |
Huot, RL; Meaney, MJ; Plotsky, PM; Thrivikraman, KV | 1 |
Baldwin, JA; Davidson, EJ; Pritchard, AL; Ridings, JE | 1 |
5 trial(s) available for paroxetine and Body Weight
Article | Year |
---|---|
Chronic social stress during adolescence: interplay of paroxetine treatment and ageing.
Topics: Adrenal Glands; Aging; Animals; Arginine Vasopressin; Body Weight; Chronic Disease; Corticosterone; Corticotropin-Releasing Hormone; Dexamethasone; Disease Models, Animal; Exploratory Behavior; Gene Expression Regulation; Longitudinal Studies; Male; Mice; Paroxetine; Receptors, Glucocorticoid; Selective Serotonin Reuptake Inhibitors; Social Isolation; Stress, Psychological; Thymus Gland | 2013 |
Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.
Topics: Adult; Aged; Body Mass Index; Body Weight; Female; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Single-Blind Method | 2014 |
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Body Weight; Cardiovascular Diseases; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Duloxetine Hydrochloride; Electrocardiography; Female; Hemodynamics; Humans; Longitudinal Studies; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Thiophenes | 2004 |
Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling.
Topics: Age Factors; Aged; Body Weight; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Genotype; Humans; Male; Nonlinear Dynamics; Paroxetine; Polymerase Chain Reaction; Racial Groups; Selective Serotonin Reuptake Inhibitors; Sex Factors | 2006 |
Weight change in older depressed patients during acute pharmacotherapy with paroxetine and nortriptyline: a double-blind randomized trial.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Body Weight; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Nortriptyline; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Weight Gain; Weight Loss | 2000 |
34 other study(ies) available for paroxetine and Body Weight
Article | Year |
---|---|
Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study.
Topics: Body Weight; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Fluoxetine; Humans; Paroxetine; Phenotype; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2022 |
Fadogia agrestis (Schweinf. Ex Hiern) Stem Extract Restores Selected Biomolecules of Erectile Dysfunction in the Testicular and Penile Tissues of Paroxetine-Treated Wistar Rats.
Topics: Animals; Arginase; Body Weight; Catalase; Erectile Dysfunction; Humans; Hydrogen Peroxide; Male; Paroxetine; Plant Extracts; Rats; Rats, Wistar; Sildenafil Citrate; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2023 |
Safety of low-dose paroxetine.
Topics: Body Weight; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2014 |
Another option for menopausal vasomotor symptoms without negative impact on weight and sexual function.
Topics: Body Weight; Female; Hot Flashes; Humans; Menopause; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological | 2014 |
The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects.
Topics: Animals; Antidepressive Agents; Aza Compounds; Behavior, Animal; Body Weight; Bridged Bicyclo Compounds, Heterocyclic; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Ejaculation; Exploratory Behavior; Male; Olfactory Bulb; Paroxetine; Rats; Rats, Sprague-Dawley; Reaction Time; Statistics, Nonparametric | 2008 |
Unusual weight fluctuation under corticosteroid and psychotropic treatment.
Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Appetite; Aripiprazole; Body Weight; Cyclosporine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Eating; Female; Humans; Mianserin; Paroxetine; Piperazines; Prednisolone; Quinolones; Sertraline; Takayasu Arteritis | 2008 |
The risks and benefits of switching antipsychotics: a case study approach.
Topics: Antipsychotic Agents; Benzodiazepines; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertriglyceridemia; Long-Term Care; Male; Middle Aged; Olanzapine; Paroxetine; Psychotic Disorders; Risk Assessment; Schizophrenia; Thioridazine | 2009 |
Olanzapine treatment in anorexia nervosa: case report.
Topics: Adolescent; Ambulatory Care; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Body Weight; Combined Modality Therapy; Defense Mechanisms; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; MMPI; Olanzapine; Paroxetine; Psychotherapy | 2009 |
Roles of paroxetine and corticosterone on adult mammalian ciliary body cell proliferation.
Topics: Adrenal Glands; Animals; Body Weight; Cell Proliferation; Ciliary Body; Corticosterone; Immunohistochemistry; In Vitro Techniques; Male; Organ Size; Paroxetine; Rats; Rats, Sprague-Dawley | 2010 |
Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug.
Topics: Acoustic Stimulation; Age Factors; Analysis of Variance; Animals; Body Weight; Brain; Corticosterone; Critical Period, Psychological; Dose-Response Relationship, Drug; Escape Reaction; Exploratory Behavior; Fluoxetine; Immobility Response, Tonic; Longitudinal Studies; Male; Maze Learning; Paroxetine; Rats; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Sensory Gating | 2011 |
Sub-chronic dietary tryptophan depletion--an animal model of depression with improved face and good construct validity.
Topics: Aldosterone; Analysis of Variance; Animals; Body Weight; Brain; Calcium-Binding Proteins; Catecholamines; Chromatography, High Pressure Liquid; Corticosterone; Depression; Diet; Disease Models, Animal; DNA-Binding Proteins; Kynurenic Acid; Kynurenine; Male; Nerve Tissue Proteins; Nucleobindins; Paroxetine; Protein Binding; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Swimming; Time Factors; Tritium; Tryptophan | 2012 |
Effect of chronic treatment with milnacipran on sleep architecture in rats compared with paroxetine and imipramine.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Cyclopropanes; Imipramine; Male; Milnacipran; Paroxetine; Rats; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Stages; Sleep, REM; Wakefulness | 2002 |
Implantation of a slow release corticosterone pellet induces long-term alterations in serotonergic neurochemistry in the rat brain.
Topics: Adrenal Glands; Animals; Body Weight; Carrier Proteins; Corticosterone; Depression; Disease Models, Animal; Drug Implants; Frontal Lobe; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Organ Size; Paroxetine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time | 2003 |
Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development.
Topics: Age Factors; Animals; Animals, Newborn; Body Weight; Carrier Proteins; Female; Immunohistochemistry; Isoenzymes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neural Pathways; Paroxetine; Phospholipase C beta; Pregnancy; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Somatosensory Cortex; Thalamus; Type C Phospholipases; Vibrissae | 2004 |
Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies.
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drinking; Drug Interactions; Glycemic Index; Hyperalgesia; Idazoxan; Infusion Pumps, Implantable; Male; Pain Measurement; Pain Threshold; Paroxetine; Pyrazoles; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Spinal Cord; Streptozocin; Time Factors | 2004 |
Effect of repeated administration of paroxetine and electroconvulsive shock on the proliferative response of lymphocytes and the synthesis of nitric oxide by macrophages in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Body Weight; Cell Division; Drug Administration Schedule; Electroshock; Lipopolysaccharides; Lymphocytes; Macrophages, Peritoneal; Male; Nitric Oxide; Organ Size; Paroxetine; Rats; Rats, Wistar; Spleen | 2005 |
Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Radiation; Drug Interactions; Fluvoxamine; Inhibition, Psychological; Male; Maze Learning; Paroxetine; Rats; Rats, Wistar; Reaction Time; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Sexual Behavior, Animal; Swimming | 2006 |
Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Body Weight; Depression; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Food Preferences; Glucocorticoids; Male; Paroxetine; Rats; Rats, Wistar; Stress, Psychological; Time Factors | 2007 |
Anorexia nervosa with chronic episodes for more than 30 years in a patient with a comorbid schizotypal personality disorder.
Topics: Anorexia Nervosa; Antidepressive Agents, Second-Generation; Benzodiazepines; Body Weight; Bulimia; Chronic Disease; Female; Hospitalization; Humans; Mianserin; Middle Aged; Olanzapine; Paroxetine; Schizotypal Personality Disorder; Selective Serotonin Reuptake Inhibitors | 2007 |
Long-term administration of dexfenfluramine to genetically obese (ob/ob) and lean mice: body weight and brain serotonin changes.
Topics: Animals; Blood Glucose; Body Weight; Brain Chemistry; Corticosterone; Dietary Fats; Female; Fenfluramine; Mice; Mice, Inbred C57BL; Mice, Obese; Norfenfluramine; Obesity; Paroxetine; Serotonin | 1994 |
Programming of brainstem serotonin transporter development by prenatal glucocorticoids.
Topics: Animals; Binding Sites; Body Weight; Brain Stem; Carrier Proteins; Cell Differentiation; Cell Division; Dexamethasone; Female; Glucocorticoids; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurons; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tritium | 1996 |
Protective effect of citalopram against the attenuation of the alpha 1-potentiation of cAMP formation in Fischer 344 strain rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Citalopram; Cyclic AMP; Depression; Imipramine; Male; Motor Activity; Nerve Tissue Proteins; Paroxetine; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, Adrenergic, alpha-1; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 1997 |
Long-term food restriction down-regulates the density of serotonin transporters in the rat frontal cortex.
Topics: Aging; Animals; Body Weight; Carrier Proteins; Down-Regulation; Frontal Lobe; Male; Membrane Glycoproteins; Membrane Transport Proteins; Membranes; Mesencephalon; Nerve Tissue Proteins; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Starvation | 1997 |
Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential.
Topics: Animals; Appetite Depressants; Body Weight; Brain Chemistry; Discrimination, Psychological; Fenfluramine; In Vitro Techniques; Indans; Male; Nervous System Diseases; Neurotransmitter Uptake Inhibitors; Norfenfluramine; Paroxetine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Serotonin; Synaptosomes | 1998 |
Modeling geriatric depression in animals: biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats.
Topics: Adenylyl Cyclases; Aging; Animals; Antidepressive Agents, Second-Generation; Avoidance Learning; Behavior, Animal; Body Weight; Brain; Carrier Proteins; Depressive Disorder; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Nerve Tissue Proteins; Olfactory Bulb; Paroxetine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Reflex, Startle; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1999 |
Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people.
Topics: Aged; Antidepressive Agents, Second-Generation; Body Weight; Female; Fluoxetine; Humans; Hyponatremia; Male; Paroxetine; Retrospective Studies; Risk Factors; Time Factors | 1999 |
Feeding and reward interactions from chronic paroxetine treatment.
Topics: Animals; Body Weight; Conditioning, Operant; Dose-Response Relationship, Drug; Electrodes, Implanted; Feeding Behavior; Male; Medial Forebrain Bundle; Paroxetine; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Reward; Selective Serotonin Reuptake Inhibitors; Stereotaxic Techniques | 1999 |
Behavioral changes in developing mice after prenatal exposure to paroxetine (Paxil)
Topics: Aggression; Animals; Animals, Newborn; Anxiety; Behavior, Animal; Body Weight; Depression; Exploratory Behavior; Female; Homing Behavior; Litter Size; Male; Maternal Exposure; Mice; Motor Activity; Paroxetine; Play and Playthings; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Selective Serotonin Reuptake Inhibitors; Sleep; Time Factors; Vocalization, Animal | 1999 |
Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Weight; Cyclohexanols; Desipramine; Drinking Behavior; Eating; Endotoxins; Escherichia coli; Interleukin-10; Lipopolysaccharides; Male; Motor Activity; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 1999 |
Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites.
Topics: Animals; Binding Sites; Body Weight; Carrier Proteins; Cell Size; Chronic Disease; Corticosterone; Dendrites; Female; Hippocampus; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Pyramidal Cells; Radioligand Assay; Rats; Rats, Long-Evans; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Stress, Psychological | 2000 |
Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Body Weight; Female; Humans; Leptin; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Nortriptyline; Paroxetine; Receptors, Leptin; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2000 |
The toxicity profile of a single dose of paroxetine: an alternative approach to acute toxicity testing in the rat.
Topics: Animal Testing Alternatives; Animals; Behavior, Animal; Body Temperature; Body Weight; Dose-Response Relationship, Drug; Drinking; Eating; Erythrocytes; Female; Hematocrit; Hemoglobins; Liver; Models, Animal; Motor Activity; Organ Size; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2001 |
Development of adult ethanol preference and anxiety as a consequence of neonatal maternal separation in Long Evans rats and reversal with antidepressant treatment.
Topics: Adrenocorticotropic Hormone; Alcohol Drinking; Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Anxiety; Body Weight; Corticosterone; Female; Male; Maternal Deprivation; Paroxetine; Pituitary-Adrenal System; Rats; Rats, Long-Evans; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2001 |
The reproductive toxicology of paroxetine.
Topics: Abnormalities, Drug-Induced; Animals; Antidepressive Agents; Body Weight; Dose-Response Relationship, Drug; Female; Litter Size; Paroxetine; Piperidines; Pregnancy; Pregnancy, Animal; Rabbits; Rats; Serotonin Antagonists | 1989 |